ProfileGDS4095 / 226444_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 64% 62% 63% 60% 61% 62% 61% 59% 65% 60% 61% 61% 62% 64% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep15.4728664
GSM709769LY2 SRC1-siRNA tamoxifen treated rep35.1285662
GSM709765LY2 SRC1-siRNA untreated rep35.3843663
GSM709771LY2 SRC1-siRNA untreated rep14.8012660
GSM709772LY2 SRC1-siRNA untreated rep24.9271261
GSM709775LY2 SRC1-siRNA untreated rep45.064362
GSM709764LY2 control-siRNA tamoxifen treated rep24.9256761
GSM709766LY2 control-siRNA tamoxifen treated rep34.6009959
GSM709768LY2 control-siRNA tamoxifen treated rep15.6363665
GSM709777LY2 control-siRNA tamoxifen treated rep44.7233260
GSM709770LY2 control-siRNA untreated rep34.9941761
GSM709773LY2 control-siRNA untreated rep14.8480361
GSM709774LY2 control-siRNA untreated rep25.16462
GSM709776LY2 control-siRNA untreated rep45.4868664